|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Furiex Pharmaceuticals, Inc. (FURX) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
10,015,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
49,855 |
Avg
Vol: |
49,716 |
| 52
Week Range: |
$106.18 - $106.18 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Davis Stephen |
Director |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
9,308 |
|
- |
|
| Mcintyre Gail Frances |
Senior Vice President-Research |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
29,868 |
|
- |
|
| Kaldor Stephen W |
Director |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
7,160 |
|
- |
|
| Dixon Wendy L |
Director |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
7,160 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,580 |
8,447 |
|
- |
|
| Patel Sailash |
Chief Financial Officer |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
27,948 |
|
- |
|
| Covington Paul S |
Senior VP-Clinical Operations |
• • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
13,500 |
28,623 |
|
- |
|
| Almenoff June Sherie |
President |
• • – |
2014-02-04 |
4 |
AS |
$114.60 |
$13,271,221 |
D/D |
(115,113) |
24,600 |
|
- |
|
| Almenoff June Sherie |
President |
• • – |
2014-02-04 |
4 |
OE |
$9.11 |
$1,368,575 |
D/D |
115,113 |
139,713 |
|
- |
|
| Patel Sailash |
Chief Financial OfficerOfficer |
• – – |
2013-11-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
14,948 |
|
- |
|
| Patel Sailash |
Chief Financial Officer |
• • – |
2013-11-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
15,948 |
|
- |
|
| Covington Paul S |
Senior VP-Clinical Operations |
• • – |
2013-09-10 |
4 |
S |
$40.89 |
$1,226,700 |
D/D |
(30,000) |
15,123 |
|
- |
|
| Covington Paul S |
Senior VP-Clinical Operations |
• • – |
2013-09-10 |
4 |
OE |
$9.11 |
$273,300 |
D/D |
30,000 |
45,123 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2013-08-09 |
4 |
S |
$39.74 |
$298,050 |
D/D |
(7,500) |
3,580 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2013-08-09 |
4 |
OE |
$9.11 |
$68,325 |
D/D |
7,500 |
11,080 |
|
- |
|
| Mcintyre Gail Frances |
Senior Vice President-Research |
• • – |
2013-07-19 |
4/A |
AS |
$40.00 |
$800,000 |
D/D |
(20,000) |
17,868 |
|
- |
|
| Mcintyre Gail Frances |
Senior Vice President-Research |
• • – |
2013-07-19 |
4 |
AS |
$40.00 |
$423,240 |
D/D |
(10,581) |
17,868 |
|
- |
|
| Mcintyre Gail Frances |
Senior Vice President-Research |
• • – |
2013-07-19 |
4 |
D |
$40.00 |
$376,760 |
D/D |
(9,419) |
28,449 |
|
- |
|
| Mcintyre Gail Frances |
Senior Vice President-Research |
• • – |
2013-07-19 |
4 |
OE |
$9.11 |
$182,200 |
D/D |
20,000 |
37,868 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2013-07-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
15 |
3,580 |
|
- |
|
| Eshelman Fredric N |
Director |
• • • |
2013-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
7,161 |
2,673,522 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2013-06-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,913 |
3,595 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2013-06-28 |
4 |
S |
$34.03 |
$13,102 |
D/D |
(385) |
6,508 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2013-06-25 |
4/A |
OE |
$9.11 |
$9,110 |
D/D |
1,000 |
8,180 |
|
- |
|
| Corr Peter B |
Director |
• • – |
2013-06-25 |
4 |
D |
$33.30 |
$13,319 |
D/D |
(400) |
6,893 |
|
- |
|
129 Records found
|
|
Page 2 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
